Anti-Müllerian Hormone (AMH) Programme

Home - RIQAS - Anti-Müllerian Hormone (AMH) Programme

The RIQAS Anti-Mullerian Hormone (AMH) Programme will be run at a frequency of 1 sample per month. The samples will be in a lyophilised format.

  • Lyophilised material for enhanced stability
  • Submit results and view reports online via RIQAS.Net
  • High quality reliable controls – Randox has 30 plus years’ experience as a global manufacturer of QC controls
  • Worlds largest EQA scheme ensuring peer groups are maximised
  • Monthly reporting to reduce the risk of errors

        What is AMH used for?

        AMH is made in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on age and gender.

        An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. A woman’s ovaries can make thousands of eggs during her childbearing years. the number declines as a woman gets older. AMH levels help show how many potential egg cells a woman has left. This is known as the ovarian reserve. 

        If a woman’s ovarian reserve is high, she may have a better chance of getting pregnant. She may also be able to wait months or years before trying to get pregnant. If the ovarian reserve is low, it may mean a woman will have trouble getting pregnant and show not delay very long before trying to have a baby.

        AMH tests may also be used to:

        • Predict the start of menopause, a time in a woman’s life when her menstrual periods have stopped, and she can’t
        become pregnant anymore. It usually starts when a woman is around 50 years old.
        • Find out the reason for early menopause
        • Help find out the reason for amenorrhea, the lack of menstruation. It is most often diagnosed in girls who haven’t started
        menstruating by the age of 15 and in women who have missed several periods.
        • Help diagnose polycystic ovary syndrome (PCOS), a hormonal disorder that is a common cause of female infertility, the
        inability to get pregnant
        • Check infants with genitals that are not clearly identified as male or female
        • Monitor women who have certain types of ovarian cancer

        Join the Worlds Largest External Quality Assessment scheme today:

        DescriptionFrequencySizeCat. No
        AMHMonthly (programme begins January 2023)12 x 1mlRQ9198


          RIQAS Programmes